BREAKING
Americas Gold and Silver Corporation (USAS) FY2025 Earnings: Misses on EPS, Revenue Recap 2 hours ago FormFactor, Inc. (FORM) Drops 6.1% to $92.00 3 hours ago Photronics, Inc. (PLAB) Drops 6.3% to $37.09 3 hours ago Amkor Technology, Inc. (AMKR) Drops 6.5% to $41.57 3 hours ago Teradyne, Inc. (TER) Drops 5.9% to $277.93 3 hours ago Lumentum Holdings Inc. (LITE) Drops 6.1% to $659.99 3 hours ago MP Materials Corp. (MP) Drops 8% to $47.53 3 hours ago Badger Meter, Inc. (BMI) Jumps 5.1% to $153.31 3 hours ago Palo Alto Networks, Inc. (PANW) Jumps 7.4% to $158 3 hours ago United Therapeutics Corporation (UTHR) Surges 14.8% to $600.09 4 hours ago Americas Gold and Silver Corporation (USAS) FY2025 Earnings: Misses on EPS, Revenue Recap 2 hours ago FormFactor, Inc. (FORM) Drops 6.1% to $92.00 3 hours ago Photronics, Inc. (PLAB) Drops 6.3% to $37.09 3 hours ago Amkor Technology, Inc. (AMKR) Drops 6.5% to $41.57 3 hours ago Teradyne, Inc. (TER) Drops 5.9% to $277.93 3 hours ago Lumentum Holdings Inc. (LITE) Drops 6.1% to $659.99 3 hours ago MP Materials Corp. (MP) Drops 8% to $47.53 3 hours ago Badger Meter, Inc. (BMI) Jumps 5.1% to $153.31 3 hours ago Palo Alto Networks, Inc. (PANW) Jumps 7.4% to $158 3 hours ago United Therapeutics Corporation (UTHR) Surges 14.8% to $600.09 4 hours ago
ADVERTISEMENT
Breaking News

Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings

Unicycive Therapeutics, Inc. (UNCY) posted Q4 2025 basic and diluted EPS of -$1.67.

March 30, 2026 1 min read

Unicycive Therapeutics, Inc. (UNCY) posted Q4 2025 basic and diluted EPS of -$1.67.

UNCYUNCY|EPS -$1.67|Net Loss $26.6M

Unicycive Therapeutics, Inc. (UNCY) posted FY 2025 basic and diluted EPS of -$1.67.

Unicycive Therapeutics, Inc. is a Biotechnology company. Bottom line showed a net loss of $26.6M.

Wall Street consensus stands at 10 buy, 1 hold, 0 sell.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

ADVERTISEMENT